Steward Partners Investment Advisory, LLC Mei Pharma, Inc. Transaction History

Steward Partners Investment Advisory, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$2.33 - $3.37 $18,640 - $26,960	-8,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$2.6 - $3.65 $1,300 - $1,825	500 Added 6.67%	8,000 $23,000
Q1 2021 May 14, 2021	BUY	$2.73 - $4.5 $20,475 - $33,750	7,500 New	7,500 $25,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $362M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.